NL176071C - N-alkylpiperidinederivaten; werkwijze voor de bereiding van farmaceutische preparaten met anti-diabetische werking. - Google Patents
N-alkylpiperidinederivaten; werkwijze voor de bereiding van farmaceutische preparaten met anti-diabetische werking.Info
- Publication number
- NL176071C NL176071C NLAANVRAGE7805253,A NL7805253A NL176071C NL 176071 C NL176071 C NL 176071C NL 7805253 A NL7805253 A NL 7805253A NL 176071 C NL176071 C NL 176071C
- Authority
- NL
- Netherlands
- Prior art keywords
- preparation
- pharmaceutical preparations
- diabetic action
- alkylpiperidine derivatives
- alkylpiperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP52075936A JPS5943459B2 (ja) | 1977-06-25 | 1977-06-25 | N−アルキルピペリジン誘導体 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7805253A NL7805253A (nl) | 1978-12-28 |
NL176071B NL176071B (nl) | 1984-09-17 |
NL176071C true NL176071C (nl) | 1985-02-18 |
Family
ID=13590624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NLAANVRAGE7805253,A NL176071C (nl) | 1977-06-25 | 1978-05-16 | N-alkylpiperidinederivaten; werkwijze voor de bereiding van farmaceutische preparaten met anti-diabetische werking. |
Country Status (12)
Country | Link |
---|---|
US (1) | US4182767A (xx) |
JP (1) | JPS5943459B2 (xx) |
AT (1) | AT365576B (xx) |
BE (1) | BE868329A (xx) |
CH (1) | CH633264A5 (xx) |
DE (1) | DE2824781C3 (xx) |
DK (1) | DK149749C (xx) |
FR (1) | FR2420529A1 (xx) |
GB (1) | GB1555654A (xx) |
IT (1) | IT1104743B (xx) |
NL (1) | NL176071C (xx) |
SE (1) | SE430333B (xx) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO154918C (no) * | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
DE2830469A1 (de) * | 1978-07-11 | 1980-01-24 | Bayer Ag | Herstellung von l-desoxy-nojirimycin und n-substituierten derivaten |
DE2835069A1 (de) * | 1978-08-10 | 1980-02-21 | Bayer Ag | N-amino-3,4,5-trihydroxypiperidine, ihre herstellung und verwendung |
DE2839309A1 (de) * | 1978-09-09 | 1980-03-27 | Bayer Ag | 3,4,5-trihydroxypiperidin-derivate |
DE2848117A1 (de) * | 1978-11-06 | 1980-05-14 | Bayer Ag | Derivate des 2-hydroxymethyl-3,4,5- trihydroxy-piperidins, ihre herstellung und verwendung zur beeinflussung des kohlenhydrat- und fettstoffwechsels |
JPS55118415A (en) * | 1979-02-28 | 1980-09-11 | Pii Papahadojiyopo Dometoriosu | Method of encapsulating biologically active substance in lipoid cell |
DE2925943A1 (de) * | 1979-06-27 | 1981-01-29 | Bayer Ag | 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE2942365A1 (de) * | 1979-10-19 | 1981-05-14 | Bayer Ag, 5090 Leverkusen | 2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
JPS56108768A (en) * | 1980-01-28 | 1981-08-28 | Nippon Shinyaku Co Ltd | Cinnamylmoranoline derivative |
JPS56108767A (en) * | 1980-01-28 | 1981-08-28 | Nippon Shinyaku Co Ltd | Bismoranoline derivative |
DE3007078A1 (de) * | 1980-02-26 | 1981-09-10 | Bayer Ag, 5090 Leverkusen | Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung |
DE3620645A1 (de) * | 1985-12-20 | 1987-07-02 | Bayer Ag | 3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung |
US5192772A (en) * | 1987-12-09 | 1993-03-09 | Nippon Shinyaku Co. Ltd. | Therapeutic agents |
US4849430A (en) * | 1988-03-09 | 1989-07-18 | Monsanto Company | Method of inhibiting virus |
US4999360A (en) * | 1987-12-21 | 1991-03-12 | Monsanto Company | Method of inhibiting virus |
US5089520A (en) * | 1987-12-21 | 1992-02-18 | Monsanto Company | Method of inhibiting virus |
EP0344383A1 (en) * | 1988-06-02 | 1989-12-06 | Merrell Dow Pharmaceuticals Inc. | Novel alpha-Glucosidase inhibitors |
US5043416A (en) * | 1988-09-26 | 1991-08-27 | Monsanto Company | Method of inhibiting virus |
US4937357A (en) * | 1988-11-03 | 1990-06-26 | G. D. Searle & Co. | Intermediates for antiviral compounds |
US4973602A (en) * | 1988-11-03 | 1990-11-27 | G. D. Searle & Co. | Antiviral compounds and a method of use thereas |
US5144037A (en) * | 1988-11-03 | 1992-09-01 | G. D. Searle & Co. | 1,5-dideoxy-1,5-imino-d-glucitol derivatives |
US4876268A (en) * | 1988-11-03 | 1989-10-24 | G. D. Searle & Co. | Antiviral compounds and use thereof |
US5003072A (en) * | 1988-11-03 | 1991-03-26 | G. D. Searle & Co. | 1,5-dideoxy-1,5-imino-D-glucitol derivatives |
US5221746A (en) * | 1988-11-03 | 1993-06-22 | G. D. Searle & Co. | 1,5-dideoxy-1,5-imino-D-glucitol derivatives |
US5310745A (en) * | 1988-11-03 | 1994-05-10 | G. D. Searle & Co. | Antiviral compounds |
US4957926A (en) * | 1988-12-22 | 1990-09-18 | Monsanto Company | Method of treating herpesviruses |
US5043273A (en) * | 1989-08-17 | 1991-08-27 | Monsanto Company | Phosphorylated glycosidase inhibitor prodrugs |
US5103008A (en) * | 1989-08-17 | 1992-04-07 | Monsanto Company | Compound, N-butyl-deoxynojirimycin-6-phosphate |
US5536732A (en) * | 1990-04-27 | 1996-07-16 | Merrell Pharmaceuticals Inc. | N-derivatives of 1-deoxy nojirimycin |
US5252587A (en) * | 1990-04-27 | 1993-10-12 | Merrell Dow Pharmaceuticals, Inc. | N-derivatives of 1-deoxy nojirimycin |
EP0453692A1 (en) * | 1990-04-27 | 1991-10-30 | Merrell Dow Pharmaceuticals Inc. | Novel nojirimycin derivatives |
US5151519A (en) * | 1990-05-07 | 1992-09-29 | G. D. Searle & Co. | Process for the preparation of 1,5-(alkylimino)-1,5-dideoxy-d-glucitol and derivatives thereof |
US5504078A (en) * | 1990-06-08 | 1996-04-02 | Merrell Dow Pharmaceuticals Inc. | α-glucosidase inhibitors |
US5342951A (en) * | 1992-04-01 | 1994-08-30 | G.D. Searle & Co. | 2- and 3-sulfur derivatives of 1,5-iminosugars |
US5798366A (en) * | 1993-05-13 | 1998-08-25 | Monsanto Company | Method for treatment of CNS-involved lysosomal storage diseases |
US5399567A (en) * | 1993-05-13 | 1995-03-21 | Monsanto Company | Method of treating cholera |
US6291657B1 (en) * | 1993-05-13 | 2001-09-18 | Monsanto Company | Deoxygalactonojirimycin derivatives |
US6037351A (en) * | 1994-01-13 | 2000-03-14 | G. D. Searle & Co. | Method of inhibiting hepatitis B virus |
US20030100532A1 (en) | 1997-02-14 | 2003-05-29 | Gary S. Jacob | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
AU753336B2 (en) | 1997-11-10 | 2002-10-17 | G.D. Searle & Co. | Use of alkylated iminosugars to treat multidrug resistance |
US6689759B1 (en) | 1998-02-12 | 2004-02-10 | G. D. Searle & Co. | Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy |
JP2002502875A (ja) | 1998-02-12 | 2002-01-29 | ジー・ディー・サール・アンド・カンパニー | 肝炎ウイルス感染症を処置するためのn−置換−1,5−ジデオキシ−1,5−イミノ−d−グルシトール化合物の使用 |
ATE402701T1 (de) * | 1999-02-12 | 2008-08-15 | United Therapeutics Corp | N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen |
JP2003505501A (ja) | 1999-02-12 | 2003-02-12 | ジー・ディー・サール・アンド・カンパニー | 肝炎ウィルス感染の処置のためのグルカミン化合物 |
US20050032841A1 (en) * | 1999-04-20 | 2005-02-10 | Steven Walkley | Therapeutic compositions and methods of treating glycolipid storage related disorders |
GB9909066D0 (en) | 1999-04-20 | 1999-06-16 | Oxford Glycosciences Uk Ltd | Therapies |
WO2004106299A2 (en) * | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Substituted pyrrole derivatives and their use as hmg-co inhibitors |
WO2006053043A2 (en) * | 2004-11-10 | 2006-05-18 | Genzyme Corporation | Methods of treating diabetes mellitus |
WO2007054896A1 (en) * | 2005-11-08 | 2007-05-18 | Ranbaxy Laboratories Limited | Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
WO2008020314A2 (en) * | 2006-03-14 | 2008-02-21 | Ranbaxy Laboratories Limited | Statin stabilizing dosage formulations |
WO2007134086A2 (en) * | 2006-05-09 | 2007-11-22 | Genzyme Corporation | Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis |
RU2009105089A (ru) * | 2006-07-14 | 2010-08-27 | Ранбакси Лабораториз Лимитед (In) | ПОЛИМОРФНЫЕ ФОРМЫ ГМГ-КоА-РЕДУКТАЗЫ И ИХ ПРИМЕНЕНИЕ |
CA2666814A1 (en) * | 2006-08-21 | 2008-05-29 | United Therapeutics Corporation | Combination therapy for treatment of viral infections |
US8097728B2 (en) * | 2007-04-30 | 2012-01-17 | Philadelphia Health & Education Corporation | Iminosugar compounds with antiflavirus activity |
EP2594563B1 (en) | 2007-05-31 | 2018-07-18 | Genzyme Corporation | 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
US8912177B2 (en) | 2007-10-05 | 2014-12-16 | Genzyme Corporation | Method of treating polycystic kidney diseases with ceramide derivatives |
CA2731685A1 (en) | 2008-07-28 | 2010-02-04 | Genzyme Corporation | Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease |
CA2738768C (en) * | 2008-10-03 | 2017-10-31 | Genzyme Corporation | 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
CN106420740A (zh) | 2009-02-23 | 2017-02-22 | 伊莫根特病毒学有限责任公司 | 亚氨基糖以及治疗病毒性疾病的方法 |
KR101787434B1 (ko) * | 2009-02-24 | 2017-11-15 | 유나이티드 세러퓨틱스 코오포레이션 | 이미노슈가 및 아레나바이러스성 감염을 치료하는 방법 |
KR101463661B1 (ko) * | 2009-06-12 | 2014-11-19 | 유나이티드 세러퓨틱스 코오포레이션 | 면역당 및 분야바이러스 및 토가바이러스 질환의 치료 방법 |
CN105748476A (zh) * | 2009-09-04 | 2016-07-13 | 联合治疗公司 | 亚氨基糖以及治疗丝状病毒性疾病的方法 |
ES2485623T3 (es) * | 2009-09-04 | 2014-08-13 | United Therapeutics Corporation | Procedimiento para el tratamiento de infecciones por poxvirus |
PL2473482T3 (pl) * | 2009-09-04 | 2014-09-30 | United Therapeutics Corp | Metody leczenia zakażeń ortomyksowirusowych |
BR112018072298A2 (pt) | 2016-05-02 | 2019-02-12 | Florida State University Research Foundation, Inc. | tratamento de infecções pelo vírus da zika usando inibidores da alfa-glicosidase |
US11369592B2 (en) | 2020-02-21 | 2022-06-28 | Florida State University Research Foundation, Inc. | Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4065562A (en) * | 1975-12-29 | 1977-12-27 | Nippon Shinyaku Co., Ltd. | Method and composition for reducing blood glucose levels |
DE2660486C2 (de) * | 1975-12-29 | 1984-03-08 | Nippon Shinyaku Co., Ltd., Kyoto | Verwendung von 2-Hydroxymethyl-3,4,5-trihydroxypiperidin als Arzneimittel |
-
1975
- 1975-09-11 GB GB37406/75A patent/GB1555654A/en not_active Expired
-
1977
- 1977-06-25 JP JP52075936A patent/JPS5943459B2/ja not_active Expired
-
1978
- 1978-05-10 SE SE7805329A patent/SE430333B/sv not_active IP Right Cessation
- 1978-05-10 US US05/906,233 patent/US4182767A/en not_active Expired - Lifetime
- 1978-05-16 NL NLAANVRAGE7805253,A patent/NL176071C/xx not_active IP Right Cessation
- 1978-05-22 FR FR7815143A patent/FR2420529A1/fr active Granted
- 1978-06-06 DE DE2824781A patent/DE2824781C3/de not_active Expired
- 1978-06-07 IT IT49760/78A patent/IT1104743B/it active
- 1978-06-15 DK DK269178A patent/DK149749C/da not_active IP Right Cessation
- 1978-06-16 CH CH661178A patent/CH633264A5/de not_active IP Right Cessation
- 1978-06-21 AT AT0451778A patent/AT365576B/de not_active IP Right Cessation
- 1978-06-21 BE BE188742A patent/BE868329A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CH633264A5 (de) | 1982-11-30 |
SE7805329L (sv) | 1978-12-26 |
BE868329A (fr) | 1978-10-16 |
AT365576B (de) | 1982-01-25 |
DE2824781B2 (xx) | 1980-01-31 |
DK269178A (da) | 1978-12-26 |
FR2420529A1 (fr) | 1979-10-19 |
DE2824781A1 (de) | 1979-01-04 |
SE430333B (sv) | 1983-11-07 |
IT1104743B (it) | 1985-10-28 |
IT7849760A0 (it) | 1978-06-07 |
ATA451778A (de) | 1981-06-15 |
JPS5943459B2 (ja) | 1984-10-22 |
GB1555654A (en) | 1979-11-14 |
FR2420529B1 (xx) | 1984-10-12 |
DK149749B (da) | 1986-09-22 |
NL7805253A (nl) | 1978-12-28 |
US4182767A (en) | 1980-01-08 |
DE2824781C3 (de) | 1980-09-18 |
JPS5412381A (en) | 1979-01-30 |
DK149749C (da) | 1987-03-02 |
NL176071B (nl) | 1984-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL176071C (nl) | N-alkylpiperidinederivaten; werkwijze voor de bereiding van farmaceutische preparaten met anti-diabetische werking. | |
NL175991C (nl) | Werkwijze voor de bereiding van tetrafluorethaan. | |
NL189085C (nl) | Werkwijze voor de bereiding van octafluorpropaan. | |
NL7703729A (nl) | Werkwijze voor de bereiding van pour-on-prepa- raten van anthelmintica. | |
NL188407C (nl) | Werkwijze voor de bereiding van d(-)-alfa-fenylglycine. | |
NL7605539A (nl) | Werkwijze voor de bereiding van preparaten met analgetische en bloeddrukverlagende werking. | |
NL7513230A (nl) | Werkwijze voor de bereiding van farmaceutische tabletten. | |
NL7610607A (nl) | Werkwijze voor de bereiding van rodenticide- preparaten. | |
NL175819C (nl) | Werkwijze voor de bereiding van moranoline. | |
NL7610057A (nl) | Werkwijze voor de bereiding van farmaceutische preparaten. | |
NL7705457A (nl) | Werkwijze voor de bereiding van 2.3-dimethylpen- tanal. | |
NL187065C (nl) | Werkwijze voor de bereiding van styryldifenylamine. | |
NL7803995A (nl) | Werkwijze voor de bereiding van pyridoxine. | |
NL7607693A (nl) | Werkwijze voor de bereiding van tegen ontste- kingen werkende en bloeddrukverlagende prepara- ten. | |
NL186699C (nl) | Kanamycine-derivaten, werkwijze voor de bereiding daarvan, werkwijze voor de bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten. | |
NL7800026A (nl) | Werkwijze voor de bereiding van gesubstitueerde amino-benzenen. | |
NL7704149A (nl) | Werkwijze voor de bereiding van titaantrichlori- depreparaten. | |
NL7800067A (nl) | Werkwijze voor de bereiding van een farmaceu- tisch preparaat. | |
NL188998C (nl) | Werkwijze voor de bereiding van indolinederivaten. | |
NL7812393A (nl) | Werkwijze voor de bereiding van 1-hydroxyaporfine-deri- vaten. | |
NL7803629A (nl) | Werkwijze voor de bereiding van gefosforileerde amidi- nen. | |
NL7801277A (nl) | Werkwijze voor het bereiden van farmaceutische preparaten, waarbij 1,2-butaandiol-1-methyl- ether als oplosmiddel wordt toegepast. | |
NL7812567A (nl) | Werkwijze voor de bereiding van menselijke chorionso- matomammotropine. | |
NL7601115A (nl) | Werkwijze voor de bereiding van herbicide prepa- raten. | |
NL7713862A (nl) | Werkwijze ter bereiding van op de 2-plaats ge- disubstitueerde fenyl-3.4-dihydro-4-oxochinazo- linederivaten, alsmede farmaceutische preparaten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
V1 | Lapsed because of non-payment of the annual fee |
Effective date: 19971201 |